ALTSHULER DAVID (EVP, Global Research and CSO) sold 3.7% of their position (1.27K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $610.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/28/2025ACC: 0000875320-25-000120
Officer· EVP, Global Research and CSO
Since Jun 2018
-7.23K
Net shares
Net seller
$3.47M
Total sold
1
Open market trades
0B · 1S
2
Total transactions
7.23K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.95K
Price / share
$479.61
Trade value
$2.86M
% of position
14.8%
2/26/2025
40.20K→34.25K
Common Stock
Direct
Shares
−1.27K
Price / share
$480.00
Trade value
$610.56K
% of position
3.7%
2/27/2025
34.25K→32.97K
Total
Net shares
−7.23K
Net value
-$3.47M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2025 | F · Tax Withholding | −5.95K | $479.61 | $2.86M | 14.8% | 40.20K | 34.25K |
| Common Stock Direct | 2/27/2025 | S · Sale | −1.27K | $480.00 | $610.56K | 3.7% | 34.25K | 32.97K |
| Total | −7.23K | -$3.47M | ||||||
Derivative Transactions0
No derivative transactions reported